These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34231823)

  • 21. Genomic evidence of SARS-CoV-2 reinfection cases in southern Brazil.
    Varela APM; Sant'Anna FH; Dos Santos AV; Prichula J; Comerlato J; Dos Santos GT; Wendland E
    Arch Virol; 2023 Jan; 168(1):19. PubMed ID: 36593369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mild reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant: First case report from Indonesia.
    Isnaini N; Mardian Y; Lokida D; Budiono F; Butar-Butar DP; Arlinda D; Salim G; Kosasih H; Wulan WN; Perodin J; Neal A; Lane HC; Karyana M
    Front Med (Lausanne); 2022; 9():906469. PubMed ID: 35935779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reinfection rate in a cohort of healthcare workers over 2 years of the COVID-19 pandemic.
    Guedes AR; Oliveira MS; Tavares BM; Luna-Muschi A; Lazari CDS; Montal AC; de Faria E; Maia FL; Barboza ADS; Leme MD; Tomazini FM; Costa SF; Levin AS
    Sci Rep; 2023 Jan; 13(1):712. PubMed ID: 36639411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 variant N.9 identified in Rio de Janeiro, Brazil.
    Tort LFL; Ribeiro IP; Menezes LSR; Dos Santos AAC; Santos MP; Damasceno L; Silva PCR; de Siqueira MAMT; Brasil P; Bonaldo MC
    Mem Inst Oswaldo Cruz; 2021; 116():e210166. PubMed ID: 34755818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2 Variant Pathogenesis Following Primary Infection and Reinfection in Syrian Hamsters.
    Plunkard J; Mulka K; Zhou R; Tarwater P; Zhong W; Lowman M; Wong A; Pekosz A; Villano J
    mBio; 2023 Apr; 14(2):e0007823. PubMed ID: 37036339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic Surveillance of SARS-CoV-2 Lineages Indicates Early Circulation of P.1 (Gamma) Variant of Concern in Southern Brazil.
    Wink PL; Ramalho R; Monteiro FL; Volpato FCZ; Willig JB; Lovison OVA; Zavascki AP; Barth AL; Martins AF
    Microbiol Spectr; 2022 Feb; 10(1):e0151121. PubMed ID: 35171035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prior aerosol infection with lineage A SARS-CoV-2 variant protects hamsters from disease, but not reinfection with B.1.351 SARS-CoV-2 variant.
    Yinda CK; Port JR; Bushmaker T; Fischer RJ; Schulz JE; Holbrook MG; Shaia C; de Wit E; van Doremalen N; Munster VJ
    Emerg Microbes Infect; 2021 Dec; 10(1):1284-1292. PubMed ID: 34120579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The First Case of Immunity Loss and SARS-CoV-2 Reinfection by the Same Virus Lineage in Amazonia.
    Ferrante L; Livas S; Steinmetz WA; Almeida ACL; Leão J; Vassão RC; Tupinambás U; Fearnside PM; Duczmal LH
    J Racial Ethn Health Disparities; 2021 Aug; 8(4):821-823. PubMed ID: 34155594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study.
    Graham MS; Sudre CH; May A; Antonelli M; Murray B; Varsavsky T; Kläser K; Canas LS; Molteni E; Modat M; Drew DA; Nguyen LH; Polidori L; Selvachandran S; Hu C; Capdevila J; ; Hammers A; Chan AT; Wolf J; Spector TD; Steves CJ; Ourselin S
    Lancet Public Health; 2021 May; 6(5):e335-e345. PubMed ID: 33857453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 reinfection and COVID-19 severity.
    Nguyen NN; Houhamdi L; Hoang VT; Delerce J; Delorme L; Colson P; Brouqui P; Fournier PE; Raoult D; Gautret P
    Emerg Microbes Infect; 2022 Dec; 11(1):894-901. PubMed ID: 35264078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative Assessment of Severe Acute Respiratory Syndrome Coronavirus 2 Variants in the Ferret Model.
    Pulit-Penaloza JA; Belser JA; Sun X; Pappas C; Brock N; Kieran TJ; Ritter JM; Seixas JN; Jones J; Basu Thakur P; Pusch E; Wang L; Tumpey TM; Wentworth DE; Zhou B; Maines TR
    mBio; 2022 Oct; 13(5):e0242122. PubMed ID: 36135377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of symptoms, comorbidities, and reinfections in individuals infected with Wild-Type SARS-CoV-2, Delta, or Omicron variants: a comparative study in western Mexico.
    Peña Rodríguez M; Hernández Bello J; Vega Magaña N; Viera Segura O; García Chagollán M; Ceja Gálvez HR; Mora Mora JC; Rentería Flores FI; García González OP; Muñoz Valle JF
    Front Public Health; 2023; 11():1149795. PubMed ID: 37181688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 Reinfection and Severity of the Disease: A Systematic Review and Meta-Analysis.
    Nguyen NN; Nguyen YN; Hoang VT; Million M; Gautret P
    Viruses; 2023 Apr; 15(4):. PubMed ID: 37112949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 Reinfection Rate and Outcomes in Saudi Arabia: A National Retrospective Study.
    Al-Otaiby M; Krissaane I; Al Seraihi A; Alshenaifi J; Qahtani MH; Aljeri T; Zaatari E; Hassanain M; Algwizani A; Albarrag A; Al-Mozaini M; Alabdulaali M
    Int J Infect Dis; 2022 Sep; 122():758-766. PubMed ID: 35840098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-CoV-2 immune response and reinfection in vaccinated Maya and mestizo in Southeast of Mexico.
    Monteón V; León-Pérez F; Ancona-León JG; Gutiérrez-Torres G
    Salud Publica Mex; 2023 Dec; 66(1, ene-feb):14-16. PubMed ID: 38065105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retrospective review of re-positive qPCR tests for SARS-CoV: do they indicate presence of reinfection?
    Temiz H; Özbek E; Yıldız Zeyrek F
    Eur Rev Med Pharmacol Sci; 2022 Jul; 26(14):5278-5284. PubMed ID: 35916828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case of COVID-19 reinfection in a hemodialysis patient: the role of antibody in SARS-CoV-2 infection.
    Beppu H; Ogawa T; Ishikane M; Kawanishi T; Fukuda T; Sato L; Matsunaga A; Maeda K; Katagiri D; Ishizaka Y; Mitsuya H; Ohmagari N; Yasui F; Kohara M; Kikuchi K; Wakai S
    CEN Case Rep; 2022 Nov; 11(4):422-427. PubMed ID: 35266095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid Emergence and Epidemiologic Characteristics of the SARS-CoV-2 B.1.526 Variant - New York City, New York, January 1-April 5, 2021.
    Thompson CN; Hughes S; Ngai S; Baumgartner J; Wang JC; McGibbon E; Devinney K; Luoma E; Bertolino D; Hwang C; Kepler K; Del Castillo C; Hopkins M; Lee H; DeVito AK; Rakeman JL; ; Fine AD
    MMWR Morb Mortal Wkly Rep; 2021 May; 70(19):712-716. PubMed ID: 33983915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiological and clinical characteristics of COVID-19 reinfection during the epidemic period in Yangzhou city, Jiangsu province.
    Wang Y; Liang J; Yang H; Zhu L; Hu J; Xiao L; Huang Y; Dong Y; Wu C; Zhang J; Zhou X
    Front Public Health; 2023; 11():1256768. PubMed ID: 37780420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid screening for SARS-CoV-2 variants of concern in clinical and environmental samples using nested RT-PCR assays targeting key mutations of the spike protein.
    La Rosa G; Mancini P; Bonanno Ferraro G; Veneri C; Iaconelli M; Lucentini L; Bonadonna L; Brusaferro S; Brandtner D; Fasanella A; Pace L; Parisi A; Galante D; Suffredini E
    Water Res; 2021 Jun; 197():117104. PubMed ID: 33857895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.